Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Clinical trial NCT02956382 · COMPLETED
Trial details
- NCT number
- NCT02956382
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2023-05-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.